Kinase inhibitors in cancer therapy: a look ahead

Area of Science:

• Cellular biology
• Molecular oncology
• Biochemistry

Background:

• Kinases are crucial for cell signaling pathways, including receptor activation, signal transduction, and cell cycle regulation.
• Aberrant kinase activity, through mutation, amplification, or overexpression, is frequently observed in various tumors.
• Understanding kinase interconnections is vital for comprehending their roles in both normal cellular processes and disease states.

Purpose of the Study:

• To review the essential kinases involved in critical cellular functions and their interconnections.
• To highlight the implications of kinase dysregulation in tumor development.
• To discuss the potential of kinase inhibitors as therapeutic agents and the necessity of advanced cellular models for drug discovery.

Main Methods:

• Literature review of essential kinases.
• Analysis of kinase roles in cell signaling, cell cycle, and programmed cell death.
• Discussion of kinase alterations in cancer and therapeutic strategies.

Main Results:

• Identified key kinases regulating fundamental cellular processes.
• Established the link between kinase gene mutations/amplification/overexpression and tumorigenesis.
• Demonstrated the potential of targeting kinases for developing small molecule inhibitors.

Conclusions:

• Kinase inhibitors represent a promising avenue for cancer therapy.
• The complex interconnections of kinases and the existence of unknown signaling proteins necessitate the use of cellular test systems for effective drug screening.
• Overexpressing key kinases or their partners in cellular models can aid in the development of targeted therapies.